相似文献
1
Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy.
Blood. 2012 Nov 29;120(23):4488-95. doi: 10.1182/blood-2012-05-423236. Epub 2012 Jul 20.
2
Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy.
Hematology Am Soc Hematol Educ Program. 2012;2012:313-21. doi: 10.1182/asheducation-2012.1.313.
3
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol. 2021 Feb;22(2):223-234. doi: 10.1016/S1470-2045(20)30601-X.
4
A randomized trial of brief treatment of early- stage Hodgkin lymphoma: Is it effective?
Hematol Oncol Stem Cell Ther. 2012;5(1):36-41. doi: 10.5144/1658-3876.2012.36.
5
Evidence-based focused review of the role of radiation therapy in the treatment of early-stage Hodgkin lymphoma.
Blood. 2015 Mar 12;125(11):1708-16. doi: 10.1182/blood-2014-08-545152. Epub 2015 Jan 20.
6
Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma.
Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):199-205. doi: 10.1016/j.ijrobp.2010.09.007.
7
Current role and future developments of radiotherapy in early-stage favourable Hodgkin's lymphoma.
Strahlenther Onkol. 2007 Dec;183 Spec No 2:16-8. doi: 10.1007/s00066-007-2007-4.
8
Quality control of involved-field radiotherapy for patients with early stage Hodgkin's lymphoma based on a central prospective review. Comparison of the results between two study generations of the German Hodgkin Study Group.
Strahlenther Onkol. 2012 Aug;188(8):660-5. doi: 10.1007/s00066-012-0103-6. Epub 2012 Jun 14.
9
Combination chemoradiotherapy in early Hodgkin lymphoma.
Hematol Oncol Clin North Am. 2014 Feb;28(1):33-47. doi: 10.1016/j.hoc.2013.10.010.
10
Treatment of lymphocyte-predominant Hodgkin lymphoma.
Ann Oncol. 2008 Jun;19 Suppl 4:iv45-6. doi: 10.1093/annonc/mdn194.
引用本文的文献
1
Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors.
Clin Med Insights Oncol. 2017 Sep 26;11:1179554917731072. doi: 10.1177/1179554917731072. eCollection 2017.
2
The evolving role of response-adapted PET imaging in Hodgkin lymphoma.
Ther Adv Hematol. 2016 Apr;7(2):108-25. doi: 10.1177/2040620715625615.
3
Omitting or reducing radiotherapy in childhood or adolescence Hodgkin Lymphoma.
Transl Pediatr. 2013 Jul;2(3):126-30. doi: 10.3978/j.issn.2224-4336.2013.06.03.
4
How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus.
Blood. 2015 Feb 19;125(8):1226-35; quiz 1355. doi: 10.1182/blood-2014-08-551598. Epub 2014 Dec 11.
5
The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease.
Blood. 2014 Nov 27;124(23):3356-64. doi: 10.1182/blood-2014-05-577627.
6
Balancing risks and benefits of therapy for patients with favorable-risk limited-stage Hodgkin lymphoma: the role of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy alone.
Hematol Oncol Clin North Am. 2014 Feb;28(1):49-63. doi: 10.1016/j.hoc.2013.10.001.
7
Is radiation dose reduction the right answer for HPV-positive head and neck cancer?
Oral Oncol. 2014 Jun;50(6):560-4. doi: 10.1016/j.oraloncology.2013.09.015. Epub 2013 Oct 14.
8
Classical Hodgkin's lymphoma: the Lymphoma Study Association guidelines for relapsed and refractory adult patients eligible for transplant.
Haematologica. 2013 Aug;98(8):1185-95. doi: 10.3324/haematol.2012.072090.
本文引用的文献
1
Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496).
J Clin Oncol. 2013 Feb 20;31(6):684-91. doi: 10.1200/JCO.2012.43.4803. Epub 2012 Nov 26.
2
Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial.
Ann Oncol. 2013 Apr;24(4):1044-8. doi: 10.1093/annonc/mds542. Epub 2012 Nov 7.
3
Evidence, preferences, recommendations--finding the right balance in patient care.
N Engl J Med. 2012 May 3;366(18):1653-5. doi: 10.1056/NEJMp1201535.
4
Risk of developing cardiovascular disease after involved node radiotherapy versus mantle field for Hodgkin lymphoma.
Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1232-7. doi: 10.1016/j.ijrobp.2011.09.020. Epub 2012 Jan 21.
5
Positron emission tomography in the management of Hodgkin lymphoma.
Hematology Am Soc Hematol Educ Program. 2011;2011:317-22. doi: 10.1182/asheducation-2011.1.317.
6
ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma.
N Engl J Med. 2012 Feb 2;366(5):399-408. doi: 10.1056/NEJMoa1111961. Epub 2011 Dec 11.
7
Hodgkin lymphoma.
J Natl Compr Canc Netw. 2011 Sep 1;9(9):1020-58. doi: 10.6004/jnccn.2011.0086.
8
Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2011 Sep;22 Suppl 6:vi55-8. doi: 10.1093/annonc/mdr378.
9
Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study.
Ann Intern Med. 2011 Jul 5;155(1):39-51. doi: 10.7326/0003-4819-155-1-201107050-00006.
10
Stereotactic body radiation therapy: scope of the literature.
Ann Intern Med. 2011 Jun 7;154(11):737-45. doi: 10.7326/0003-4819-154-11-201106070-00343. Epub 2011 May 2.
Zotero 插件